Healthy Clinical Trial
Functional Magnetic Resonance Imaging of Human Hypothalamic Responses to Oral Temperature and Glucose Sensing
|Start date||January 28, 2013|
|Completion date||May 23, 2013|
The study will consist of four occasions with one week between the occasions. fMRI will be performed to monitor hypothalamic activity before and after an ingestion of 1 of the following 4 stimuli (300 ml of each): water at room temperature, water at 0 degrees Celsius, glucose solution at room temperature, glucose solution at 0 degrees Celsius. The last two stimuli both contain 75 gram glucose. The order of conditions will be randomly assigned to the subjects. Functional connectivity of the hypothalamic regions will be assessed by analysing the resting state fMRI.
Background of the study: Thermo-regulation is an important aspect of human homeostasis. A
decrease in brain and/or body temperature will increase energy requirements and eventually
food intake, which acts as a defence against hypothermia. The hypothalamus plays a central
role in the regulation of temperature as well as in the control of energy intake, feeding
behaviour and lipid and glucose metabolism. The effect of both cooling and changes in energy
demand, will therefore be reflected in hypothalamic activity.
Functional magnetic resonance imaging (fMRI) is a non-invasive method, which detects transient haemodynamic changes in the brain, using blood oxygen level dependent (BOLD) signal differences in response to external or internal stimuli. Recently, several fMRI studies have shown the feasibility of measuring hypothalamic function in response to glucose ingestion.
In order to investigate the role of hypothalamic neural activity in response to cooling by food temperature and the additional effect of glucose concentration, fMRI will be performed in healthy men after ingestion of one of 4 solutions at different temperatures and with different glucose concentration.
The study will consist of four occasions. There will be an interval of at least one week between the occasions. On all occasions, the subject will be admitted to the Clinical Research Unit of the LUMC. After a acclimatisation period of 30 minutes and anthropometric measurements (weight and height), fMRI to monitor hypothalamic activity will be performed after an ingestion of 1 of the following 4 stimuli (300 ml of each): water at room temperature, water almost frozen (0 C), glucose solution at room temperature, almost frozen glucose solution (0 C). The last two stimuli both contain 75 gram glucose. Conditions will be randomly assigned to the subjects, a batch wise randomisation procedure will be followed. The order of allocation of each subject is recorded on paper and stored in a sealed envelop, which will be opened after inclusion in the study. The hypothalamus will be continuously imaged for 20 min. (8 min baseline, 4 min drinking, 8 min post ingestion) using a conventional T2*-weighted gradient-echo pulse sequence. A resting state fMRI will be carried out before and after the fMRI of the hypothalamic activity. Hedonic changes or reward effects of the administration will be captured by separate analysis of the amygdala and nucleus accumbens in each subject.
|Terminated||NCT00001844 - Study of New Magnetic Resonance Methods||N/A|
|Completed||NCT02235961 - Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects||Phase 1|
|Completed||NCT00527579 - PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FB||Phase 1|
|Completed||NCT00526916 - PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28||Phase 1|
|Recruiting||NCT02509494 - Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo During Implementation of Stages 1 and 2||Phase 3|
|Terminated||NCT02555085 - Single Ascending Doses of BIIB063 in Healthy Volunteers||Phase 1|
|Completed||NCT03125018 - Accuracy of SpO2 for Noninvasive Pulse Oximeter Sensor (LNCS ADTX)||N/A|
|Completed||NCT03124901 - Accuracy of Noninvasive Pulse Oximeter Measurement of Hemoglobin for Rainbow DCI Sensor||N/A|
|Completed||NCT00091533 - Neural Correlates of Observation of Tactile Stimulation in Healthy Subjects||N/A|
|Completed||NCT00068926 - VRC 300: Screening of Healthy Volunteers for Clinical Trials of Investigational Vaccines to Prevent Infectious Diseases||N/A|
|Completed||NCT02947139 - Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20161 in Healthy Volunteers||Phase 1|
|Completed||NCT00538798 - PET Imaging of Brain mGluR5 Receptors Using [18F]SP203||Phase 1|
|Completed||NCT00097461 - Revising Employee Benefits for the Sake of Health||N/A|
|Completed||NCT00001936 - Electrical Muscle Stimulation to Aid Swallowing in Dysphagia||N/A|
|Completed||NCT00004556 - The Effects of Dextroamphetamine on Brain Function||N/A|
|Recruiting||NCT03119909 - Cognitive Adaptation||N/A|
|Completed||NCT03179345 - Simulated Driving Performance, Daytime Sedation and Cognition in Healthy Volunteers Taking Gralise, Neurontin or Lyrica||Phase 4|
|Completed||NCT02911870 - A Thorough QTc Trial Evaluating the Effect of SNAC on Cardiac Repolarisation in Healthy Male Subjects||Phase 1|
|Completed||NCT03056898 - Health Professional Dietary Habits and Blood Omega-3 Fatty Acid Concentrations||N/A|
|Completed||NCT02543567 - A Study to Evaluate A Range of Dose Levels of Ad26.ZEBOV and MVA‐BN‐Filo in Healthy Adult Participants||Phase 3|